Probiotics, An Approach towards Modern Medication

Saima Nazir, Majeeda Rasheed, Oshaz Fatima, Eisha Tu Raazi, Madiha Fayyaz


Coronaviruses (CoVs) are enveloped, positive-sense, single-stranded RNA viruses. SARS-CoV-2 is a beta coronavirus, a genus that includes several coronaviruses (SARS-CoV, MERS-CoV, bat SARS-like CoV, and others) isolated from humans, bats, camels, civets, and other animals. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the pathogenic agent that causes the disease COVID-19. SARS-CoV-2 is thought to have emerged from an animal source, most likely a bat, and subsequently spread to humans.  While genetically closely related viruses have been isolated from Rhinolophus bats, the exact source of SARS-CoV-2 and its route of introduction into the human population have not been established. Monitoring animal infections is imperative to better understanding their epidemiological significance for animal health, biodiversity, and human health. According to evidence from risk assessments, epidemiological investigations, and experimental studies, animals play no significant role in the spread of SARS-CoV-2, which is sustained by human-to-human transmission. The possibility of Coronavirus testing by veterinary labs was considered after the Iowa State veterinary lab discovered the COVID-19 virus has a similar DNA testing process to porcine epidemic diarrhea virus (PED). PED is another form of coronavirus that killed many piglets in 2013 and was unresponsive to treatment. Several vet labs optimized their equipment and processes to test for PED, helping them determine that older pigs could recover and develop immunity against the virus. Those same labs are still set up for coronavirus testing. We in Dubai Safari Park, particularly within the laboratory Veterinary Hospital, are conducting RT-PCR analysis to test diverse animal species including non-human primates, Carnivores, small mammals, and Ungulates. Even though none of our animals show any respiratory signs, we have conducted this study to ensure that our animal collection is healthy and free of SARS-COV-2.


Probiotics; Gut microbiota; Intestinal microflora; Beneficial Bacteria

Full Text:



Kunz, A. N., M. N. James and M. P. Fairchok. 2004. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. Journal of Pediatric Gastroenterology and Nutrition, 38(4): 457-8.

Arora, M., S. Sharma and A. Baldi. 2013. Comparative insight of regulatory guidelines for probiotics in USA, India and Malaysia: A critical review. International Journal of Biotechnology for Wellness Industries, 2(2): 51–64.

Bottacini, F., M. Ventura, D. V. Sinderen and M. O. Motherway. 2014. Diversity, ecology and intestinal function of bifidobacteria. Microbial Cell Factories, 13 (Suppl 1), S4.

Besselink, M.G., H. C. V. Santvoort, E. Buskens, M. A. Boermeester, H. V. Goor, H. M. Timmerman, V. B. Nieuwenhuijs, T. L. Bollen, B. V. Ramshorst, B. J. Witteman, C. Rosman, R. J. Ploeg, M. A. Brink, A. F. Schaapherder, C. H. Dejong, P. J. Wahab, C J. V. Laarhoven, E. Harst E, C. H. Eijck, M. A. Cuesta, L. M. Akkermans and H. G. Gooszen. 2008. Probiotic prophylaxis predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet, 23: 651-659.

Pedone, C. A., A. O. Bernabeu, E. R. Postaire, C. F. Bouley and P. Reinert. 1999. Effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhea in children attending day care centres. International Journal of Clinical Practice, 53: 179-184.

Chomarat, M. and D. Espinouse. 1991. Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidimevancomycin. European Journal of Clinical Microbiology and Infectious Diseases, 10: 44.

Cotter, P. D., C. Hill and R. P. Ross. 2005. Bacteriocins: Developing innate immunity for food. Nature Reviews Microbiology, 3:777-788.

Duary, R. K., M. A. Bhausaheb, V. K. Batish and G. Grover. 2011. Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Molecular Biology Reports, 39(4): 4765-4775.

Isolauri, E., P. V. Kirjavainen and S. Salminen. 2002. Probiotics: a role in the treatment of intestinal infection and inflammation. Gut, 50 (Suppl 3): III54-9.

Isolauri, E., T. Arvola, Y. Sütas, E. Moilanen and S. Salminen. 2000. Probiotics in the management of atopic eczema. Clinical and Experimental Allergy, 30(11): 1604-10.

Stanton, S. Emms and Sia. 2011. Malaysia's Market for Functional Foods, Nutraceuticals and Organic Foods. An Introduction for Canadian Producers and Exporters. Counsellor and Regional Agri-Food Trade Commissioner, Southeast Asia.

Forssten, S. D., S. J. Lahtinen, C. Arthur and A. C. Ouwehand. 2011. The intestinal microbiota and probiotics. In J J Malago, J F J G Koninkx and R Marinsek-Logar (eds.). Probiotic bacteria and enteric infections. New York: Springer.

Hartman, A. L., D. M. Lough, D. K. Barupal, O. Fiehn, T. Fishbein, M. Zasloff, J. A. Eisen. 2009. Human gut microbiome adopts an alternative state following small bowel transplantation. Proceeding of the National Academy of Sciences, U S A. 06(40):17187-92.

Hill, C., F. Guarner, G. Reid, G. R. Gibson, D. J. Merenstein, B. Pot, L. Morelli, R. B. Canani, H. J. Flint, S. Salminen, P. C. Calder and M. E. Sanders. 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic". Nature Reviews on Gastroenterology and Hepatology, 11(8): 506-14.

Husni, R. N., S. M. Gordon, J. A. Washington, D. L. Longworth. 1997. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clinical Infectious Diseases, 25(5): 1048-55.

Ishibashi, N. and S. Yamazaki. 2001. Probiotics and safety. The American Journal of Clinical Nutrition, 73(2 Suppl):465S-470S.

Levri, K. M., K. Ketvertis, M. Deramo, J. H. Merenstein and F. D'Amico. 2005. Do probiotics reduce adult lactose intolerance? A systematic review. The Journal of Family Practice, 54(7): 613-20.

Kailasapathy, K. and J. Chin. 2000. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunology and Cell Biology, 78(1): 80-88.

Kechagia, M., D. Basoulis, S. Konstantopoulou, D. Dimitriadi, K. Gyftopoulou, N. Skarmoutsou and E. M. Fakiri. 2013. Health benefits of probiotics: a review. ISRN Nutrition, 2: 481651.

McFarland, L. V. 2006. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. American Journal of Gastroenterology,101(4): 812-822.

Ledoux, D., V. J. Labombardi and D. Karter. 2006. Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkin's disease. International Journal of STD and AIDS, 17(4): 280-2.

Leuschner, R. G. K., T. P. Robinson, M. Hugas, P. S. Cocconcelli, F. Richard-Forget, G. Klein, T. R. Licht et al. 2010. Qualified presumption of safety (QPS): A generic risk assessment approach for biological agents notified to the European Food Safety Authority (EFSA). Trends in Food Science and Technology, 21(9): 425-435.

Lew, L. C. and M. T. Liong. 2013. Bioactives from probiotics for dermal health: Functions and benefits. Journal of Applied Microbiology, 114(5): 1241-1253.

Shi, L. H., G. R. Rahmat-Ali and M. T. Leong. 2010. Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. International Dairy Journal, 20(3): 169-175.

De-Vrese, M., A. Stegelmann, B. Richter, S. Fenselau, C. Laue and J. Schrezenmeir. 2001. Probiotics-compensation for lactase insufficiency. American Journal of Clinical Nutrition, 73: 421S-429S.

Falagas, M. E., G. I. Betsi and S. Athanasiou. 2007. Probiotics for the treatment of women with bacterial vaginosis. Clinical Microbiology and Infection, 13: 657-664.

Araya, M., C. Stanton, L. Morelli, G. Reid, M. Pineiro, et al. 2006. Probiotics in food: health and nutritional properties and guidelines for evaluation," Combined Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, Cordoba, Argentina, 1–4 October 2001, and Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada, 30 April–1 May 2002 [FAO Food and Nutrition paper 85], pp. 1–50, Rome, Italy:World Health Organization (WHO), Food and Agricultural Organization (FAO) [of the United Nations], ISBN 9251055130.

Manichanh, C., L. Rigottier-Gois, E. Bonnaud et al. 2006. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut, 55(2): 205-211.

Masdea, L., E. M. Kulik, I. Hauser-Gerspach, A. M. Ramseier, A. Filippi and T. Waltimo. 2012. Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Archives of Oral Biology, 57(8): 1041-1047.

Maskell, R. and Pead, L. 1992. 4-Fluoroquinolones and Lactobacillus spp as emerging pathogens. Lancet, 339, 929.

Mastromarino, P., S. Macchia, P. Brigidi, F. Pirovano, D. Matteuzzi et al. 2000. Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. European Journal of Pharmaceutics and Biopharmaceutics, 50(3): 389-95.

Morgan, X. C., T. L. Tickle, H. Sokol et al. 2012. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biology, 13(9): R79.

Shah, N. P. 2007. Functional cultures and health benefits. International Dairy Journal, 17: 1262-1277.

Nase, L., K. Hatakka, E. Savilahti, M. Saxelin, A. Ponka and T. Poussa. 2001. Effect of long-term consumption of aprobiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Research, 35(6): 412-420.

Ouwehand, A. C. and S. Salminen. 2003. In vitro adhesion assays for probiotics and their in vivo relevance: A review. Microbial Ecology in Health and Disease, 15(4): 175-184.

Peran, L., D. Camuesco, M. Comalada, A. Nieto, A. Concha, M. P. Diaz-Ropero, M. Olivares, J. Xaus, A. Zarzuelo and J. Galvez. 2005. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World Journal of Gastroenterology, 11(33): 5185-5192.

Ramos, C. L., E. A. Esteves, N. M. Z. De-Miranda, L. G. Moreno and R. F. Schwan. 2022. Non-Lactic Acid Bacteria as Probiotics and their Functional Roles. In Probiotics, Prebiotics and Synbiotics (eds P.S. Panesar and A.K. Anal).

Relman, D. A. and S. Falkow. 2001. The meaning and impact of the human genome sequence for microbiology. Trends in Microbiology, 9: 206-208.

Rijkers, G. T., W. M. De-Vos, R. J. Brummer, L. Morelli, G. Corthier and P. Marteau. 2011. Health benefits and health claims of probiotics: Bridging science and marketing. British Journal of Nutrition, 106(9): 1291-6.

Moslehi-Jenabian, S., D. S. Nielsen and L. Jespersen. 2011. Application of molecular biology and genomics of probiotics for enteric cytoprotection, in Probiotic Bacteria and Enteric Infections. Cytoprotection By Probiotic Bacteria, J. J. Malago, J. F. J. G. Koninkx and R. Marinsek-Logar, Eds., pp. 133–153, Springer, New York, NY, USA.

Salminen, C., M. C. Bouley, Boutron-Ruault et al. 1998. Functional food science and gastrointestinal physiology and function. British Journal of Nutrition, 80: S147–S171.

Sazawal, S., G. Hiremath, U. Dhingra, P. Malik, S. Deb and R. E. Black. 2006. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. The Lancet Infectious Diseases, 6: 374-382.

Savage, D. C. 1977. Microbial ecology of the gastrointestinal tract. Annual Review in Microbiology, 31: 107-133.

Jorgen, S. 2012. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. FAO / WHO.

Servin, A. L. 2004. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiology Reviews, 28: 405-440.

Shimauchi, H., G. Mayanagi, S. Nakaya, M. Minamibuchi, Y. Ito, K. Yamaki and H. Hirata. 2008. Improvement of periodontal condition of probiotics with Lactobacillus salivarius WB21: A randomized, double-blind, placebo-controlled study. Journal of Clinical Periodontology, 35(10): 897-905.

Weise, C., Y. Zhu, D. Ernst, A. A. Kuhl and M. Worm. 2011. Oral administration of Escherichia coli Nissle 1917 prevents allergen-induced dermatitis in mice. Experimental Dermatology, 20(10): 805-809.

Yesilova, Y., O. Calka, N. Akdeniz and M. Berktas. 2012. Effect of probiotics on the treatment of children with atopic dermatitis. Annals of Dermatology, 24(2): 189-193.

Zocco, M. A., D. V. L. Zileri, F. Cremonini, A. C. Piscaglia, E. C. Nista, M. Candelli, M. Novi et al. 2006. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Elementary Pharmacology and Therapeutics, 23(11): 1567-1574.



  • There are currently no refbacks.

Copyright (c) 2023 Saima Nazir

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Journal of Zoo Biology
ISSN: 2706-9761 (Online), 2706-9753 (Print)
© EScience Press. All Rights Reserved.